NIH 3T3 fibroblasts expressing oncogenic human ErbB2 treated with NK-92- ErbB2 targeting CAR cells resulted in a reduction in tumour growth in a xenograft model compared to tumours treated with unmodified NK-92 [90]. The gene discussed is ERBB2; the disease is neoplasm.